TORONTO, March 04, 2019 -- InvestorsHub NewsWire --
Blueberries Medical Corp. (CSE:BBM) (BBRRF) (1OA.F) (the
“Company” or "Blueberries"), a
leading Colombia-based licensed producer of medicinal cannabis and
cannabis-derived products, announces today that its common shares
are now listed on the Frankfurt Stock Exchange (FSE) trading under
the ticker symbol “1OA”. The Company’s common shares are also
listed on the Canadian Stock Exchange and on the OTC in the United
States.
“Listing on the Frankfurt
Stock Exchange is an important milestone for Blueberries,
consistent with our global strategy which includes exports to the
European market,” stated Camilo Villalba, Chief Operating Officer.
“It will allow us to broaden our shareholder base to include more
investors based in Europe as cannabis markets continue to expand
globally.”
About Blueberries Medical
Corp.
Blueberries is a Colombia-based licensed producer of naturally
grown premium quality cannabis with its primary operations ideally
located in the Bogotá Savannah of central Colombia. Led by a
specialized team with proprietary expertise in agriculture,
genetics, extraction, medicine, pharmacology and marketing,
Blueberries is fully licensed for the cultivation, production,
domestic distribution, and international export of CBD and
THC-based medical cannabis. Blueberries’ combination of leading
scientific expertise, agricultural advantages and distribution
arrangements has positioned the Company to become a leading
international supplier of naturally grown, processed, and
standardized medicinal-grade cannabis oil extracts and related
products.
Additional information about the
Company is available at www.blueberriesmed.com. For more
information, please contact:
Camilo Villalba, Chief Operating
Officer
Tel: +57.313.483.0131
Email: cvillalba@blueberriesmed.com
Jessika Angarita, Pacta
Relations
angarita@pactarelations.com
Tel: +1 (305) 877 4710
Cautionary Note Regarding Forward-Looking
Information
This news release contains "forward-looking information" and
"forward-looking statements" (collectively, "forward looking
statements") within the meaning of the applicable Canadian
securities legislation. All statements, other than statements
historical fact, are forward-looking statements and are based on
expectations, estimates and projections as at the date of this news
release. Any statement that involves discussions with respect to
predictions, expectations, beliefs, plans, projections, objectives,
assumptions, future events or performance (often but not always
using phrases such as “expects”, or “does not expect”, “is
expected”, “anticipates” or “does not anticipate”, “plans”,
“budget”, “scheduled”, “forecasts”, “estimates”, “believes” or
“intends” or variations of such words and phrases or stating that
certain actions, events or results “may” or “could”, “would”,
“might” or “will” be taken to occur or be achieved) are not
statements of historical fact and may be forward-looking
statements. In this news release, forward looking statements
relate, among other things, to future expansion plans in
Europe.
These forward-looking statements are
based on reasonable assumptions and estimates of management of the
Company at the time such statements were made. Actual future
results may differ materially as forward-looking statements involve
known and unknown risks, uncertainties and other factors which may
cause the actual results, performance or achievements of the
Company to materially differ from any future results, performance
or achievements expressed or implied by such forward-looking
statements. Such factors, among other things, include: fluctuations
in general macroeconomic conditions; fluctuations in securities
markets; expectations regarding the size of the Colombian and
international medical cannabis market and changing consumer habits;
the ability of the Company to successfully achieve its business
objectives; plans for expansion; political and social
uncertainties; inability to obtain adequate insurance to cover
risks and hazards; and the presence of laws and regulations that
may impose restrictions on cultivation, production, distribution
and sale of cannabis and cannabis related products in Colombia or
internationally; and employee relations. Although the
forward-looking statements contained in this news release are based
upon what management of the Company believes, or believed at the
time, to be reasonable assumptions, the Company cannot assure
shareholders that actual results will be consistent with such
forward-looking statements, as there may be other factors that
cause results not to be as anticipated, estimated or intended.
Readers should not place undue reliance on the forward-looking
statements and information contained in this news release. The
Company assumes no obligation to update the forward-looking
statements of beliefs, opinions, projections, or other factors,
should they change, except as required by law.
Additional information regarding the Company, and other
risks and uncertainties relating to the Company's business are
contained under the heading "Risk Factors" in the Company's Listing
Statement dated January 31, 2019 filed on its issuer profile on
SEDAR at www.sedar.com.
No stock exchange, securities
commission or other regulatory authority has approved or
disapproved the information contained herein
Blueberries Medical (QB) (USOTC:BBRRF)
Historical Stock Chart
From Oct 2024 to Nov 2024
Blueberries Medical (QB) (USOTC:BBRRF)
Historical Stock Chart
From Nov 2023 to Nov 2024
